Qiaoying Hu
Overview
Explore the profile of Qiaoying Hu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gao Z, Xu Q, Zhang F, Hong Y, Hu Q, Yu Q, et al.
J Appl Clin Med Phys
. 2024 Sep;
25(11):e14502.
PMID: 39231180
Purpose: This paper describes the implementation of an instantaneous low-dose-rate total body irradiation (TBI) technique using block-filtered 6 MV X-rays with a linear accelerator (LINAC) to reduce pulmonary toxicity. Methods:...
2.
Cao C, Fang Y, Jiang F, Jin Q, Jin T, Huang S, et al.
Cancer Sci
. 2024 May;
115(8):2729-2737.
PMID: 38806289
Because of the common physical condition, reduced organ function, and comorbidities, elderly patients with nasopharyngeal carcinoma (NPC) are often underrepresented in clinical trials. The optimal treatment of elderly patients with...
3.
Wang R, Hu Q, Huang S, Fang Y, Kong X, Kaur P, et al.
ACS Appl Mater Interfaces
. 2024 Jan;
16(3):4071-4088.
PMID: 38194589
Surgical resection remains the most common method of tumor treatment; however, the high recurrence and metastasis after surgery need to be solved urgently. Herein, we report an injectable zwitterionic hydrogel...
4.
Fang Y, Huang S, Hu Q, Zhang J, King J, Wang Y, et al.
ACS Nano
. 2023 Oct;
17(24):24883-24900.
PMID: 37883579
Surgical resection is the first-line therapy for breast cancer. However, residual tumor cells and the highly immunosuppressive tumor microenvironment (TME) continue to have a serious impact on tumor recurrence and...
5.
Cao C, Xu Y, Huang S, Jiang F, Jin T, Jin Q, et al.
Front Oncol
. 2021 Dec;
11:763114.
PMID: 34966674
Purpose: We sought to define the locoregional extension patterns of nasopharyngeal carcinomas (NPCs) by positron emission tomography (PET)/magnetic resonance imaging (MRI) and to improve clinical target volume (CTV) delineation. Methods:...
6.
Piao Y, Cao C, Xu Y, Huang S, Jiang F, Jin T, et al.
Eur Arch Otorhinolaryngol
. 2021 Mar;
279(1):353-359.
PMID: 33782748
Purpose: The aim of this pilot study was to evaluate the accuracy of 18 fluorodeoxyglucose (FDG) PET/MR imaging in detection and staging of recurrent or metastatic NPC. Patients And Methods:...
7.
Huang S, Piao Y, Cao C, Chen J, Sheng W, Shu Z, et al.
Oral Oncol
. 2020 Oct;
111:105025.
PMID: 33032180
Objectives: We investigated the effect of prophylactic oral nutrition supplements (ONS) in locally advanced nasopharyngeal carcinoma patients receiving neoadjuvant chemotherapy and concurrent chemoradiotherapy (CCRT). Methods: Eligible patients were randomly assigned...
8.
Liu T, Sun Q, Qin W, Chen X, Hu Q
Cancer Manag Res
. 2020 Sep;
12:8355-8362.
PMID: 32982429
Purpose: Esthesioneuroblastoma (ENB) is a type of rare malignant neoplasm of the sinonasal cavity. Optimal treatment for ENB is still controversial. A retrospective study was conducted to identify the clinical...
9.
Cao C, Yang P, Xu Y, Niu T, Hu Q, Chen X
Oral Oncol
. 2019 May;
93:91-95.
PMID: 31109702
Objective: The aim of this pilot study was to explore the integrated positron emission tomography and magnetic resonance imaging scanner (PET/MR) for biological characterization of nasopharyngeal carcinoma (NPC) and potential...
10.
Feng Y, Cao C, Hu Q, Chen X
Radiat Oncol
. 2019 Jan;
14(1):10.
PMID: 30654807
Background: The aim of this study is to evaluate the prognostic value of grading MRI-detected skull-base invasion in nasopharyngeal carcinoma (NPC) with skull-base invasion after intensity-modulated radiotherapy (IMRT). Methods: This...